AGC Biologics began its cell therapy process development and clinical manufacturing services on July 1, 2025, at its Yokohama Technical Center in Japan.
Peróxidos do Brasil, a joint venture between Solvay and Produtos Químicos Makay (PQM), announces a new strategic investment in its production unit in Chile.
Axplora to expand its Farmabios site in Gropello Cairoli, Italy, with a €35 million investment.
Vetter broke ground for the start of construction of its new clinical site in Des Plaines, Illinois, US on June 26.
Aenova is investing in a new cold storage infrastructure at its sterile site in Latina (Italy), offering an end-to-end supply chain solution for biologics and other pharmaceutical products.
Sika has acquired Gulf Additive Factory in the State of Qatar. The company manufactures a wide range of construction chemical products.
Celltrion UK has officially opened its new UK headquarters at the Charter Building in Uxbridge, UK.
The Innovation Center will focus on research and development for sustainable drilling and completion, production, and stimulation processes, and will also serve as a platform for workshops and training sessions.
Neoenergia began construction of one of the first green hydrogen (H2V) power plants Brazil, located in Taguatinga with an investment of more than R$ 30 million (€ 4.7 million).
BASF has opened a new Good Manufacturing Practice (GMP) Solution Center in Wyandotte, Michigan, to support the supply of bioprocessing ingredients and excipients for the biopharma and pharmaceutical industries.
BASF has announced the successful startup of its new world-scale hexamethylenediamine (HMD) plant in Chalampé, France, construction of which began in 2022.
Syensqo, a global company specializing in advanced materials and specialty chemicals, has announced the opening of new microbiology, (eco-)toxicology, and biotechnology laboratories in Lyon, France.
Schott Pharma is investing more than €100 million in its existing site in Lukácsháza, Hungary, to expand its capacity for sterile ready-to-use (RTU) cartridges.
DuPont announced that it has expanded its sterile operations via an addition to its healthcare manufacturing facility in Heredia, Costa Rica.
Curia, a CDMO, recently shared expansion plans for facilities in Glasgow, UK, and Albuquerque, NM, US.
Nova Chemicals commissions its first polyethylene (PE) film mechanical recycling facility in Connersville, IN, US.
Siegfried announced a further expansion of its ophthalmic drug manufacturing site in El Masnou near Barcelona, Spain.
The Swiss peptide and oligonucleotide manufacturers roll out major investments across site networks in US, UK, and Switzerland
Ecolab Life Sciences has officially opened its new US Bioprocessing Applications Laboratory in Pennsylvania.
Gelest, a Mitsubishi Chemical Group company, announced the opening of its new production facility in the US.
Bristol Myers Squibb appoints Cari Gallman as EVP and invests $40 billion in the US over 5 years.
MSSA, part of the International Chemical Investors Group (ICIG), announced the expansion of its sodium methylate production unit at its La Rochelle, France, site.
Perstorp and BRB, subsidiaries of Petronas Chemicals Group (PCG), inaugurated an innovation hub in Shanghai, China. The laboratory will support growth in the region by increasing technical support for customers.
Merck Wilmington Biotech will serve as a launch and commercial production facility and the future US home for Keytruda.
Roche recently announced that it will invest $50 billion (€43.8 billion) into the United States in the next five years.
Cellasto, the world leader in Noise, Vibration and Harshness (NVH) components, is investing roughly €60 million to establish a second plant in Shanghai, China.
To meet growing demand from the pharmaceutical industry, Asahi Kasei has established Asahi Kasei Life Science to operate its bioprocess businesses under a new organizational structure.
Novo Nordisk continues its sizeable manufacturing investments to meet increasing drug demands.
Solvay has officially inaugurated its rare earths production line for permanent magnets at the La Rochelle facility, marking a significant milestone in the Group’s commitment to meeting Europe’s strategic goals.
NBE Therapeutics (NBE), a wholly owned subsidiary of Boehringer Ingelheim, officially opened its new ADC R&D facility in Basel.
New facility will focus on crosslinkers and binders, with the potential to test tens of thousands of formulations per year. Digitalization and automation enable data-driven research and development, while networked robotics allow more efficient data generation for segment-specific application testing.
Vynova Alkoxides GmbH is beginning the construction of a new alcoholates plant at Chemiepark Lülsdorf GmbH in Lülsdorf, Germany.
US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.
OMV has announced the expansion of its innovative ReOil technology at the Schwechat refinery near Vienna.
Britain’s AstraZeneca wants to invest $2.5 billion in Beijing, China to establish its sixth global strategic R&D center.
